Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry

Molecule targeting therapy using somatostatin (SS) analogues has become a widely accepted modality to treat neuroendocrine tumors (NETs), particularly gastrointestinal (GI) and pancreatic endocrine tumors. On the other hand, little is known about the expression of somatostatin receptor (SSTR) subtyp...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Mizutani, Gou, Nakanishi, Yoko, Watanabe, Noriko, Honma, Taku, Obana, Yukari, Seki, Toshimi, Ohni, Sumie, Nemoto, Norimichi
פורמט: Artigo
שפה:Inglês
יצא לאור: Japan Society of Histochemistry and Cytochemistry 2012
נושאים:
Regular Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395302/
https://ncbi.nlm.nih.gov/pubmed/22829710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1267/ahc.12006
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים